By working through both pathways, tirzepatide provides broader support for appetite control, glucose balance, and overall metabolic function than single-receptor GLP-1 therapy alone
theyre finding theyre more akin to that friend we have who says theyve simply forgotten to eat breakfast and lunch
"Je me suis vue devenir folle" Adle, une Nioise de 42 ans, regrette quant elle d'avoir pris de l'Ozempic
Also, restrictive diets, such as vegan diets, can complicate dietary vitamin intake
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 19 Gastrointestinal Adverse Effects of GLP-1 and Dual GLP-1/GIP Receptor Agonists: A Comprehensive Update in Diabetic and Obese Populations Authors Ylmaz N , Bastemir M Received 27 November 2025 Accepted for publication 13 January 2026 Published 30 January 2026 Volume 2026:19 584175 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Dr Halis Akturk Nimet Ylmaz, 1 Mehmet Bastemir 2 1 Department of Gastroenterology, SANKO University Faculty of Medicine, Gaziantep, Turkey
59 ScaleaT
